Oral anti-hyperalgesic and anti-inflammatory activity of NK1 receptor antagonists in models of inflammatory hyperalgesia of the guinea-pig
- 1 August 2000
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 87 (3) , 253-263
- https://doi.org/10.1016/s0304-3959(00)00288-8
Abstract
Pectively. Mechanical hyperalgesia was determined by measuring the withdrawal threshold to a noxious mechanical stimulus applied to the paw and thermal hyperalgesia as the withdrawal latency to a noxious thermal stimulus applied to the plantar surface. A concentration of 1.0% carrageenan (intraplantar) reduced mechanical thresholds from 124±5 to 63±3 g and thermal latencies from 19±0.4 to 4.7±0.9 s as determined 4 h after injection. The hyperalgesia persisted for over 24 h. The NK1 receptor antagonists, SDZ NKT 343, RPR100893 and SR140333, reduced mechanical hyperalgesia by 68, 36 and 27% at a dose of 30 mg kg−1 p.o., respectively. No further reduction was noted at higher doses (maximum 100 mg kg−1 p.o.). The anti-hyperalgesic effect of SDZ NKT 343 and RPR100893 peaked at 3 h while SR140333 produced maximal reversal at 1 h after oral administration. D30 values indicated significant differences between the potency of these compounds. SDZ NKT 343 was by far the most potent anti-hyperalgesic agent (D30: 1.1 mg kg−1). The D30 values for RPR100893 and SR140333 were estimated to be 17 and >100 mg kg−1, respectively. In thermal hyperalgesia, SDZ NKT 343 produced a significantly weaker anti-hyperalgesic effect with a peak of 25% reversal. The D30 value for SDZ NKT 343 was 3.89 mg kg−1. For comparison, morphine inhibited the carrageenan-induced mechanical and thermal hyperalgesia with an ED50 of 1.85 and 2.51 mg kg−1 s.c., respectively. When tested up to 300 mg kg−1 p.o., aspirin reduced carrageenan-induced mechanical and thermal hyperalgesia by 55.0 and 45.2%, respectively. In addition to the anti-hyperalgesic effects of NK1 receptor antagonists, the effects of SDZ NKT 343 and RPR100893 on plasma protein extravasation were measured in the FCA-treated knee joint of the guinea-pig. SDZ NKT 343 reversed plasma protein extravasation 2 h after administration by 60% at the oral dose of 30 mg kg−1. RPR100893 was significantly less effective with a maximum reversal of 30% at 100 mg kg−1. In comparison, indomethacin produced a 50% reversal at a 10 mg kg−1 dose. These experiments indicate that the carrageenan-induced hyperalgesia in the guinea-pig may be predictive of analgesic activity of NK1 receptor antagonists in man. NK1 receptor antagonists are active anti-hyperalgesic drugs in both mechanical and thermal hyperalgesia in the guinea-pig. In addition they inhibit plasma protein extravasation in the same species. The variability of in vivo potency and efficacy of the NK1 receptor antagonists in the mechanical hyperalgesia model is difficult to interpret as all compounds are highly effective at blocking the NK1 receptor in guinea-pig tissues. Amongst several possibilities, differences in pharmacokinetics may explain discrepancies....Keywords
This publication has 43 references indexed in Scilit:
- In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonistPublished by Elsevier ,2002
- Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of neuropathic pain in the guinea-pigNeuroscience, 1998
- The role of bradykinin B1 receptors in the maintenance of intra‐articular plasma extravasation in chronic antigen‐induced arthritisBritish Journal of Pharmacology, 1994
- Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbilsEuropean Journal of Pharmacology, 1994
- RP-67580, a specific tachykinin NK1 receptor antagonist, relieves chronic hyperalgesia in diabetic ratsEuropean Journal of Pharmacology, 1993
- Block of voltage-dependent sodium currents by the substance P receptor antagonist (±)-CP-96,345 in neurones cultured from rat cortexBritish Journal of Pharmacology, 1993
- Non-peptide antagonists, CP-96,345 and RP 67580, distinguish species variants in tachykinin NK1 receptorsBritish Journal of Pharmacology, 1993
- The non‐peptide NK1 receptor antagonist, (±)‐CP‐96,345, produces antinociceptive and anti‐oedema effects in the ratBritish Journal of Pharmacology, 1992
- Investigation into species variants in tachykinin NK1 receptors by use of the non‐peptide antagonist, CP‐96,345British Journal of Pharmacology, 1991
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976